Navigation Links
ChemoCentryx Reports that Traficet-EN Maintains Remission in Crohn's Disease at the Digestive Disease Week (DDW) 2010 Conference
Date:5/4/2010

rop15';s.prop5='External Link';s.eVar3=s.prop5;s.prop15='92776124';s.tl(this,'o','ExternalLink');" target='_blank' href="http://www.chemocentryx.com/">www.chemocentryx.com.

Any statements in this press release about ChemoCentryx's expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. These statements are often, but not always, made through the use of words or phrases such as may, believe, will, expect, anticipate, estimate, intend, predict, seek, potential, continue, plan, should, could and would or the negative of these terms or other comparable terminology. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. Some of the risks, uncertainties and assumptions that could cause actual results to differ materially from estimates or projections contained in the forward-looking statements include but are not limited to (i) the initiation, timing, progress and results of ChemoCentryx's preclinical studies and clinical trials, (ii) ChemoCentryx's ability to advance product candidates into clinical trials, (iii) GSK's exercise of its license options, (iv) the commercialization of ChemoCentryx's product candidates, (v) the implementation of ChemoCentryx's business model, strategic plans for its business, product candidates and technology, (vi) ChemoCentryx's ability to maintain and establish collaborations or obtain additional government grant funding, (vii) ChemoCentryx's estimates of its expenses, future revenues, capital requirements and its needs for additional financing, (viii) the timing or likelihood of regulatory filings and approvals, (ix) the
'/>"/>

SOURCE ChemoCentryx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354
2. ChemoCentryx Completes Enrollment of PROTECT-1, a Phase II/III Clinical Trial of CCR9 Antagonist CCX282-B (Traficet-EN(TM)) in Crohns Disease
3. PROTECT-1 Phase II/III Induction-Stage Results for ChemoCentryxs Traficet-EN(TM) Presented in Oral Session at DDW 2009 Conference
4. ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-ENs Effectiveness in Maintaining Remission in Patients with Crohns Disease
5. ChemoCentryx Initiates Clinical Trial of CCX168, A Novel Small Molecule C5aR Antagonist for the Treatment of Inflammatory and Autoimmune Diseases
6. ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference
7. ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis
8. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
9. Spherix Reports Second Quarter Earnings
10. Tapestry Reports Second Quarter 2007 Results
11. Callisto Reports on Second-Quarter 2007 Milestones
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... and ATLANTA , August 28, ... US Food and Drug Administration (FDA) cleared the MagVita TMS ... adult patients who have failed to receive satisfactory improvement from ... non-invasive technique for stimulating neural tissue in the part of ... The procedure has been proven safe and effective and MagVenture ...
(Date:8/28/2015)... , Aug. 28, 2015 , ... Dr. Ra from Biostar , Published in ,Stem ... increase of lifespan through multiple IV administration of Adipose-derived ... and life expectancy found , Commercialization within 5 ... determined the possibility that adult mesenchymal stem cells (MSCs) ...
(Date:8/28/2015)... LONDRES, 28 de agosto de 2015   ... su participación en el  Congreso de la ESC ... más recientes y novedosas, entre ellas HeartModel A.I. ... las personas y la tecnología con los protocolos ... guiar los tratamientos y permitir atención en el ...
Breaking Medicine Technology:Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 2Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 3Korean Researchers Find the Possibility that Adult Mesenchymal Stem Cells (MSCs) May Extend Lifespan 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 5
... Asthma Medication Linked to Respiratory Improvement in NYC ... ... corticosteroids (ICS),antiinflammatory treatments often prescribed for asthma, may be beneficial,in preventing ... 2007, the 73rd annual international scientific assembly,of the American College of ...
... 24 Pharmasset, Inc.,(Nasdaq: VRUS ) has ... and,Drug Administration (FDA) for R7128 for the treatment ... a prodrug of PSI-6130, an oral cytidine,nucleoside analog ... Pharmasset,s collaboration with Roche. Pharmasset is currently,enrolling a ...
Cached Medicine Technology:Inhaled Steriods Used as Preventive Treatment Post 9/11 2Inhaled Steriods Used as Preventive Treatment Post 9/11 3R7128 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection 2R7128 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection 3R7128 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection 4R7128 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection 5
(Date:8/28/2015)... ... August 28, 2015 , ... The ... honoring military veterans leading in business. Mr. Troy Mizell, Chairman of the ... inaugural Nashville Business Journal's 2015 Veterans Awards will recognize Nashville military veterans who, ...
(Date:8/28/2015)... ... , ... Dr. Gregory K. Toumayan, D.C., Q.M.E., is now treating patients with ... pain, hip pain, neck pain, stiffness, muscle spasms, and numbness. , Dr. Toumayan ... then went on to earn his title of Doctor of Chiropractic from the Palmer ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Quatela Center for Plastic Surgery ... first and only nonsurgical product approved by the Food and Drug Administration to eliminate ... and Dr. William Koenig are among the premier cosmetic surgeons in Rochester ...
(Date:8/28/2015)... IL (PRWEB) , ... August 28, 2015 , ... Mendon, ... evening of good music and good people, all for a good cause. In its ... 30th, 2015, sponsored once more by Best Drug Rehabilitation. The “Mission” of “Music With ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... ... medical evaluations for those seeking to go deep sea diving. The act ... toxicity, and decompression sickness; for these reasons, it is vital that all recreational ...
Breaking Medicine News(10 mins):Health News:MyGenetx Board Member Receives Veterans Award 2Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 2Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 3Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 3Health News:Best Drug Rehabilitation Sponsors "Music With A Mission" Concert Featuring Avenue Beat 2Health News:Healthpointe Now Offering Scuba Physicals 2
... in U.S. is 15, CDC says , , WEDNESDAY, May 6 ... continue to be mild, those who are hospitalized due to ... said Wednesday. , In fact, the median age of hospitalized ... occurs in regular seasonal flu, U.S. Centers for Disease Control ...
... exam today! , ... San Francisco, CA (Vocus) May 6, 2009 -- ... people to get an eye exam during this national campaign, in partnership ... Institute found that more than 11 million Americans have common vision problems. ...
... Strategy ReportWASHINGTON, May 6 A national alliance ... and drug abuse prevention advocates released a national ... prescription drug abuse."Rising rates of prescription drug abuse ... and can only be countered successfully by a ...
... LAS VEGAS, May 6 Results of the Clopidogrel Medco ... the anti-clotting benefits of clopidogrel (Plavix) may be reduced when ... inhibitors (PPIs). In the study, patients taking clopidogrel and ... 50% increase in the ...
... Drops While Amphetamine Use Continues to RiseRandom Drug Testing ... Cocaine use among U.S. employees and job applicants ... according to the annual Quest Diagnostics Drug Testing Index(TM) ... last year by Quest Diagnostics (NYSE: DGX ...
... for global leaders Siemens and Olympus MALVERN, Pa., ... captured six awards in the 26th Annual Healthcare ... Market Report , the National Newspaper of Healthcare ... )Mangos distinguished its work from that of more ...
Cached Medicine News:Health News:Younger Age of Severe Swine Flu Cases Worries Experts 2Health News:Younger Age of Severe Swine Flu Cases Worries Experts 3Health News:Younger Age of Severe Swine Flu Cases Worries Experts 4Health News:Younger Age of Severe Swine Flu Cases Worries Experts 5Health News:Younger Age of Severe Swine Flu Cases Worries Experts 6Health News:Younger Age of Severe Swine Flu Cases Worries Experts 7Health News:Younger Age of Severe Swine Flu Cases Worries Experts 8Health News:Younger Age of Severe Swine Flu Cases Worries Experts 9Health News:Younger Age of Severe Swine Flu Cases Worries Experts 10Health News:Younger Age of Severe Swine Flu Cases Worries Experts 11Health News:Younger Age of Severe Swine Flu Cases Worries Experts 12Health News:Younger Age of Severe Swine Flu Cases Worries Experts 13Health News:Younger Age of Severe Swine Flu Cases Worries Experts 14Health News:EyeCare America Partners with National Eye Institute During May's Healthy Vision Month 2Health News:EyeCare America Partners with National Eye Institute During May's Healthy Vision Month 3Health News:Prescription Drug Abuse Poses Public Health Threat 2Health News:SCAI Statement on 'A National Study of the Effect of Individual Proton Pump Inhibitors on Cardiovascular Outcomes in Patients Treated with Clopidogrel Following Coronary Stenting: The Clopidogrel Medco Outcomes Study' 2Health News:Cocaine Use Among U.S. Workers Declines Sharply in 2008, According to Quest Diagnostics Drug Testing Index(TM) 2Health News:Cocaine Use Among U.S. Workers Declines Sharply in 2008, According to Quest Diagnostics Drug Testing Index(TM) 3Health News:Cocaine Use Among U.S. Workers Declines Sharply in 2008, According to Quest Diagnostics Drug Testing Index(TM) 4Health News:Cocaine Use Among U.S. Workers Declines Sharply in 2008, According to Quest Diagnostics Drug Testing Index(TM) 5Health News:Cocaine Use Among U.S. Workers Declines Sharply in 2008, According to Quest Diagnostics Drug Testing Index(TM) 6Health News:Mangos Honored with 6 HMR Awards 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: